Clinical Trials Logo
  1. Home
  2. Erythema Migrans
  3. NCT02147249

Cytokines and Chemokines in Erythema Migrans

Erythema Migrans Clinical Trial

Official title:
Inflammatory Proteins, Gene Polymorphisms, and Transcriptome Profiles in Patients With Erythema Migrans

Clinical Trial Summary

The main objective of this study is to characterize the inflammatory proteins, gene polymorphisms, and transcriptome profiles in patients with erythema migrans to gain better insight into pathogenesis of early Lyme borreliosis and to define new immune modulators that could serve as biomarkers of disease activity.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02147249
Study type Interventional
Source University Medical Centre Ljubljana
Contact Dasa Stupica, MD,PhD
Phone +386 1 5222110
Email cerar.dasa@gmail.com
Status Recruiting
Phase N/A
Start date July 2013
Completion date December 31, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT01368341 - Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice Phase 4
Completed NCT01518192 - Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological Outcome Phase 4
Recruiting NCT03966014 - Different Amoxicillin Treatment Regimens in Erythema Migrans Patients N/A
Recruiting NCT03462329 - Patient's Pretreatment Expectations About Post-Lyme Symptoms N/A
Completed NCT03956212 - Inflammatory Mediators in Erythema Migrans N/A
Completed NCT03980015 - Inflammatory Responses in Solitary and Multiple Erythema Migrans
Completed NCT03505879 - Next Generation Sequencing Detection of Lyme Disease
Completed NCT02145754 - Culture Media for Borrelia Burgdorferi Sensu Lato N/A
Completed NCT03371563 - Erythema Migrans in Elderly
Completed NCT02414789 - Lyme Borreliosis and Early Cutaneous Diagnostic N/A
Completed NCT00132327 - Analysis of Lyme Disease Lesions